Clinical trial · Interventional
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
NCT00802633CI-TRIAL-00013731terminatedN/AResults postedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Enrollment was stopped after eighty patients were enrolled.
Summary
Brief summary (as posted)
Evaluate the utility/safety of an FDA-approved tissue sealing device during radical cystectomy as compared to an FDA-approved stapling device.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bladder Cancer | Malignant Bladder Neoplasm | CURATED_EXACT | 0.92 |
| Hemostasis | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ligasure tissue sealing device | Device | — | UNRESOLVED |
| Stapling device during radical cystectomy | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Stapling device
- description
- Efficacy of stapling device during radical cystectomy
- interventionNames
- Device: Stapling device during radical cystectomy
- type
- ACTIVE_COMPARATOR
- label
- Ligasure Device
- description
- Efficacy of ligasure tissue sealing device during radical cystectomy
- interventionNames
- Device: Ligasure tissue sealing device
Primary outcomes (1)
- measure
- Estimated Blood Loss
- timeFrame
- Perioperative
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
- Maximum age
- 85 Years
Show eligibility criteria text
Inclusion Criteria: * Muscle invasive bladder cancer * Male/Female gender Exclusion Criteria:
References
Publications (0)
Data not yet available
No reference posted for this study.